Inclusion Criteria:  Patients ≥ 18 years of age, Patients with confirmed leading diagnosis of asthma with or without concomitant COPD, Physician decision to start fixed triple therapy with ICS/LABA/LAMA (Trimbow MS or HS) according to its current authorised indication. The treatment decision must be made independently from participation in this NIS, Patients willing and able to sign an informed consent for use of their pseudonymised clinical data within the present non-interventional study.  Exclusion Criteria:  1) Participation in an interventional clinical trial within 30 days prior to enrolment into the present non-interventional study or planned enrolment in an interventional clinical trial during the observational period.